The first go-to-market hire is the person who decides whether your product can be sold by someone other than you. Get it right and the motion you built by hand becomes a motion a team can run. Get it wrong and you spend a year watching a talented seller bounce off a sales cycle they have never seen before, burning pipeline and goodwill that you cannot easily make back.
Selling AI into health systems, payers, and providers is a different sale, not a faster or slower version of selling software. There is a clinical champion who has to believe the thing improves care. There is a security review that can stall a deal for a quarter. There is a procurement committee that answers to people the champion has never met. The cycle is measured in quarters, not weeks, and the evidence bar is high. Buyers want proof, not promise, and they want it in a form their own institution will accept.
The candidate who has only ever sold horizontal SaaS into mid-market does not know this terrain. They know how to sell, which is not nothing. But the muscles they built (fast cycles, single economic buyer, demo-to-close) are the wrong muscles, and under quota pressure they will reach for them.
The mis-hire with the great logo page
The dangerous candidate is impressive on paper. The logo page is full of names you recognize. The numbers were good. And when you ask how they navigated a clinical champion, a CISO review, and a procurement committee in a single deal, the answer gets thin. They talk about the champion and skip the committee, or they describe security as a checkbox someone else handled. They have sold into healthcare adjacencies without ever owning the full institutional sale, and the gap is exactly where your deals will die.
This is not about pedigree. Some of the best healthcare sellers came up outside it. It is about whether the person has personally carried a deal through the parts that cannot be rushed: the long evaluation, the stakeholder who goes quiet for six weeks, the internal politics of a buying institution that is not a monolith. If they have not, you are paying them to learn on your pipeline, at the worst possible time to be learning.
Signals that someone has really done it
The people who have done this sale talk about it differently. They do not lead with their numbers. They lead with the texture: the specific people inside an account, the order in which they were won, the moment a deal nearly collapsed and what brought it back. Listen for that texture. It is hard to fake and it is the clearest signal you will get.
- They draw a stakeholder map from memory (named roles, who blocks, who champions, who has to be won before whom) rather than describing a generic funnel.
- They can point to pilots they personally converted into enterprise contracts, and explain why some pilots converted and others quietly never did.
- They describe cycles measured in quarters without flinching, and they have a feel for what keeps a long deal warm when nothing is visibly happening.
- They speak about security and compliance review as part of the sale they own, not as a hurdle the technical team clears for them.
- They are comfortable saying a deal is not real yet, because they have been burned by mistaking a champion's enthusiasm for an institution's commitment.
Anyone can sell a pilot to a believer. The job is converting the believer's institution, and most of that institution has never met you.
Sell the first deals yourself
Before you make this hire, run the first several sales yourself. Founders resist this, because selling is not what they think they are good at and the GTM hire is supposed to relieve them of it. But the early healthcare sale is the map, and you cannot delegate drawing it. Until you have walked a deal through the clinical champion, the security review, and the procurement committee, you do not actually know your own sales motion, which means you cannot scope the hire, cannot calibrate what good looks like, and cannot tell in an interview whether the candidate is describing your reality or a different one.
Selling the first deals yourself does three things. It produces a real motion the hire can inherit instead of inventing. It teaches you where your product genuinely lands and where it gets stuck, which sharpens everything from pricing to the pitch. And it makes you a far better judge of candidates, because you can hear, in their answers, whether they have stood where you have stood.
The founders who skip this step tend to hire a story they cannot verify, hand over a motion that does not exist, and conclude a year later that the seller was the problem. Sometimes the seller was the problem. More often the founder never had a motion to hand over, and no first hire, however good, can sell their way out of that.
Calibrate before you source
Once you have sold a few deals, the scorecard writes itself. You know which stakeholders gate your sale, so you can probe for whether the candidate has navigated each one. We calibrate the weighted scorecard with the founder first, then score the panel blind, because a charismatic seller can charm an unprepared interviewer into ignoring the gap that matters most. The structure is there to keep the logo page from doing your thinking for you.
The first commercial hire into healthcare AI is a bet on whether your sale can outlive you. Make the bet on someone who has already survived the cycle you are about to scale, and make it only after you have survived it yourself.